Back
Pliant Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer5.jpg)
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.
Buy
54
PLRX
Pliant Therapeutics
Last Price:
13.38
Seasonality Move:
-6.7%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer2.jpg)
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLRX is experiencing slight buying pressure.
Pliant Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.82 | Buy |
20-day SMA: | 11.9 | Buy |
50-day SMA: | 12.24 | Buy |
200-day SMA: | 14.54 | Sell |
8-day EMA: | 12.73 | Buy |
20-day EMA: | 12.26 | Buy |
50-day EMA: | 12.34 | Buy |
200-day EMA: | 14.6 | Sell |
Pliant Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 62.94 | Buy |
Chaikin Money Flow: | 260351 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.67 - 12.73) | Buy |
Bollinger Bands (100): | (11.58 - 14.72) | Buy |
Pliant Therapeutics Technical Analysis
Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 13.30 while PLRX 8-day simple moving average is 12.82, which is a Buy signal.
- The stock price of PLRX is 13.30 while Pliant Therapeutics 20-day SMA is 11.90, which makes it a Buy.
- Pliant Therapeutics 50-day simple moving average is 12.24 while PLRX share price is 13.30, making it a Buy technically.
- PLRX stock price is 13.30 and Pliant Therapeutics 200-day simple moving average is 14.54, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Buy
54
Pliant Therapeutics (PLRX)
is a Buy
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Buy
The current Pliant Therapeutics [PLRX] share price is $13.30. The Score for PLRX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
802.18M
Price in USD:
13.30
Share Volume:
629.99K
Pliant Therapeutics 52-Week Range
52-Week High:
20.23
52-Week Low:
10.29
Buy
54
Pliant Therapeutics (PLRX)
is a Buy
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 13.30 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is not overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 13.30 while PLRX 8-day exponential moving average is 12.73, which is a Buy signal.
- The stock price of PLRX is 13.30 while Pliant Therapeutics 20-day EMA is 12.26, which makes it a Buy.
- Pliant Therapeutics 50-day exponential moving average is 12.34 while PLRX share price is 13.30, making it a Buy technically.
- PLRX stock price is 13.30 and Pliant Therapeutics 200-day simple moving average is 14.60, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.27 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is 0.35, suggesting Pliant Therapeutics is a Buy
- Pliant Therapeutics Relative Strength Index (RSI) is 62.94, which suggest Pliant Therapeutics is overbought
- The Bollinger Bands (25) for Pliant Therapeutics is (10.67 - 12.73), which suggest Pliant Therapeutics is a Buy
- The Bollinger Bands (100) for Pliant Therapeutics is (11.58 - 14.72), which suggest Pliant Therapeutics is a Buy
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.